The proposal in concept is simple: Rescind rule 611 and a few other related parts of Reg NMS. Specifically, the so-called order protection rule (OPR) and Rule 610 (e), which prohibits exchanges to ...
Kardigan (Nasdaq: KARD), a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist, visits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results